A retired teacher in Connecticut spends a weekend gardening, finds a tick attached to her thigh on Sunday, and removes it. Two weeks later she has drenching night sweats, a high fever, and bone-deep fatigue. Her doctor tests for Lyme, finds it, and prescribes doxycycline. The fevers persist. A blood smear two weeks after that shows ring forms inside her red blood cells. She has babesiosis, often co-infecting in the same Lyme-endemic regions, and the antibiotics that work for Lyme do nothing for it.

CDC reported 2,418 babesiosis cases in 2022, more than double the 2015 count. The disease is now nationally notifiable in most northeastern and upper midwestern states, but case reporting still substantially undercounts true incidence. The parasite is a close cousin of Plasmodium (the malaria parasite) and produces a similar disease, with sharp differences in geography, vector, and treatment. This post fits inside the outbreak-aware travel guide and complements the Lyme disease tick prevention guide and Powassan virus.

Key Takeaways

What is babesiosis?

Babesiosis is an infection of red blood cells by Babesia parasites, single-celled protozoans related to Plasmodium. After tick inoculation, parasites invade erythrocytes, multiply, and rupture them. The disease that follows resembles malaria but with regional, ecological, and treatment differences that matter.

In the US, the dominant species is Babesia microti. Rare cases of B. duncani occur on the west coast and B. divergens-like organisms in scattered US cases. In Europe, B. divergens is the typical agent and causes more severe disease, often in asplenic patients with cattle exposure.

The parasite was first identified in cattle in the 1880s by Romanian biologist Victor Babes. The first US human case was diagnosed on Nantucket in 1969, where the disease earned the nickname "Nantucket fever." Cases have spread from that focus across coastal New England and into the upper midwest over the following decades.

How does it spread?

Three transmission routes are recognized:

  1. Tick bite. Ixodes scapularis (deer tick, blacklegged tick) is the dominant vector. Nymph-stage ticks active in late spring and early summer cause most human cases. The same tick transmits Lyme, anaplasmosis, Powassan virus, and Borrelia miyamotoi, so co-infection is common.
  2. Blood transfusion. Babesia is now the most common transfusion-transmitted infection in the US. FDA requires donor blood screening in endemic states. Cases still occur from imported blood products.
  3. Transplacental. Rare cases of congenital babesiosis have been reported.

White-footed mice (Peromyscus leucopus) are the dominant amplifying reservoir, the same animal that maintains the Lyme cycle. Deer maintain tick populations but are not significant reservoirs for the parasite itself.

The 36-hour tick attachment window for efficient Babesia transmission is similar to Lyme. Prompt tick removal substantially reduces risk.

Where is babesiosis active?

US case distribution clusters tightly in two regions:

Region Annual case rate (2022)
Massachusetts 600+
Connecticut 350+
Rhode Island 250+
New York 500+
New Jersey 250+
Minnesota 200+
Wisconsin 100+

Newer endemic foci have emerged in Maine, New Hampshire, Vermont, and northeastern Pennsylvania. Cases have also been reported from Michigan, Indiana, and as far south as Maryland. The geographic expansion mirrors the spread of Lyme disease and reflects the same drivers: tick range expansion, deer population recovery, and climate-driven changes in tick activity windows.

Cases peak in June, July, and August with smaller spring and fall shoulders. Late-season cases occur into October in warmer years.

What are the symptoms?

Symptoms appear 1 to 9 weeks after the tick bite, longer than Lyme's typical 3 to 30 days. The clinical picture is fever-dominant and resembles malaria.

Severity correlates with parasitemia level (percent of red cells infected), host immune status, and presence of spleen. Asplenic patients can develop parasitemia exceeding 80 percent with life-threatening hemolysis.

Co-infection with Lyme disease occurs in 10 to 25 percent of cases in endemic areas. Patients who do not improve on doxycycline for Lyme should be evaluated for babesiosis.

Who is at highest risk for severe disease?

Most healthy adults clear babesiosis with treatment and have full recovery. Severe disease concentrates in identifiable risk groups:

Asplenic patients should be aware of babesiosis if they live in or travel to endemic regions. Splenectomy patients with fever after tick exposure need immediate evaluation and empiric treatment until results return.

How is it diagnosed?

Diagnosis requires laboratory confirmation. Clinical suspicion alone is not enough because of overlap with malaria, viral fevers, and other tick-borne diseases.

Co-testing for Lyme disease and anaplasmosis is standard when babesiosis is on the differential, because co-infection is common in the same vector regions. The PCR vs antigen vs serology post covers test selection logic.

How is it treated?

Treatment regimens differ by severity:

Asplenic and severely immunocompromised patients may need extended treatment, sometimes for 6 weeks or more. Relapses occur and require retreatment. Drug-resistant Babesia microti has been documented after rituximab and prolonged single-agent therapy.

How do you prevent it?

Tick avoidance is the only effective prevention. There is no vaccine.

Patients planning splenectomy who live in endemic areas should know their increased post-operative risk. Splenectomized patients with febrile illness after tick exposure need urgent evaluation.

Blood donor screening in endemic states has reduced transfusion-transmitted cases substantially since FDA implementation in 2019. Recipients of blood products from endemic regions remain a small ongoing source of cases.

FAQ

Can you have babesiosis without symptoms?

Yes. Seroprevalence studies in endemic areas have found that 1 to 4 percent of residents have evidence of past Babesia infection without remembering acute illness. These asymptomatic carriers can still transmit through blood donation, which is why FDA blood donor screening matters in endemic states.

How does babesiosis differ from malaria?

Both infect red blood cells and produce similar fevers, but the parasites are different genera (Babesia vs Plasmodium), the vectors are different (ticks vs mosquitoes), the geography is different (US/Europe vs tropical regions), and the treatment is different. Antimalarial drugs like chloroquine do not treat babesiosis, and antibabesial regimens do not treat malaria.

Is babesiosis fatal?

Most cases recover with appropriate treatment. Mortality concentrates in asplenic, immunocompromised, and elderly patients, where overall mortality runs 5 to 20 percent in case series. Healthy adults with prompt diagnosis and treatment have mortality under 1 percent. Severity tracks closely with parasitemia level and host factors.

Can you get babesiosis from a dog or cat?

Babesia species infect dogs and other animals, but the species causing canine babesiosis (mainly B. canis, B. gibsoni) generally do not infect humans. There is no known direct dog-to-human transmission. Both humans and dogs in endemic areas can acquire infections independently from the same tick populations, which is why prevention overlaps with pets and zoonotic disease.

Should I worry about babesiosis after every tick bite?

In endemic states, yes, you should be aware. The most useful step is documenting the bite (date, location, how long the tick was attached) and watching for fever, sweats, or unexplained fatigue over the following 1 to 9 weeks. Prompt evaluation if symptoms develop matters far more than prophylactic testing of every bite.